Navigation Links
DFG welcomes decision on stem cell research by German parliament
Date:4/23/2008

This release is available in German.

The President of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Professor Matthias Kleiner, commented on the decision by the German Federal Parliament on the Stem Cell Act:

The Deutsche Forschungsgemeinschaft is pleased and grateful for the decision taken by Parliament. We are especially grateful to those members of Parliament who contributed towards the critical debate of the issue.

The decision taken to move the qualifying date for importing human embryonic stem cell lines is a good and important step forwards for German science and for German stem cell researchers. They will take advantage of the new possibilities with a strong sense of responsibility and according to their strict ethical principles.

First and foremost, we are very glad that the threat of legal sanctions that has existed up to now has been lifted. This was a particularly serious deterrent for young researchers wanting to go abroad.

All in all, the debate on the amendment of the Stem Cell Act is another good example of constructive dialogue between the scientific community and politics. The outcome of todays debate is also firm evidence of the confidence in the scientific community and its ability to argue its case.


'/>"/>

Contact: Dr. Eva-Maria Streier
em.streier@dfg.de
49-228-885-2250
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1

Related biology news :

1. Unconscious decisions in the brain
2. Arctic climate models playing key role in polar bear decision
3. To save or savor? Its decision time for Atlantic bluefin tuna
4. More comprehensive analysis of Klamath River basin needed to aid decision makers
5. Decisions on the second round of the Excellence Initiative announced
6. Cilia: small organelles, big decisions
7. American College of Medical Genetics responds to new FDA labeling decision for warfarin
8. McMaster University engineering professor receives Humboldt Research Award
9. Purdue researchers propose way to incorporate deforestation into climate change treaty
10. Inflammation triggers cell fusions that could protect neurons, Stanford research shows
11. Research identifies first method for testing, assessing drug treatments for Chagas disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... 27, 2017  Kinexum, a distinguished resource for research, ... the appointment of Thomas C. Seoh as ... M.D., Kinexum founder, who becomes Executive Chairman and will ... clients. Thomas Seoh commented, "I ... mission and lead the firm,s remarkable team of life ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December ... its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) ... to offer NAT screening for blood donors under an Investigational New Drug (IND) study ...
(Date:4/26/2017)... , April 26, 2017  Genisphere LLC, ... platform, has signed a collaborative and sponsored research ... Silvia Muro . The overall goal of ... pharmacodynamics of various 3DNA designs and formulations after ... targeting diseases of the vasculature as well as ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
Breaking Biology Technology: